Company Filing History:
Years Active: 2017
Title: Michael William Mosesson: Innovator in Recombinant Protein Production
Introduction
Michael William Mosesson is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. His innovative work addresses critical challenges in the dairy industry related to transgenic animals.
Latest Patents
Mosesson holds a patent for the "Use of anticoagulants in the production of recombinant proteins in the milk of transgenic animals." This invention focuses on producing recombinant human fibrinogen (rhFib) in the milk of transgenic mammals. The process is often hindered by the formation of clots and flakes in the milk, which can disrupt lactation. His invention proposes the use of anticoagulants, such as coumarins, to mitigate these issues, with warfarin being a preferred choice.
Career Highlights
Throughout his career, Mosesson has been associated with Pharming Intellectual Property Bv, where he has furthered his research and development efforts. His work has been instrumental in advancing the production of therapeutic proteins, which have significant implications for medical treatments.
Collaborations
Mosesson has collaborated with notable colleagues, including Kathryn Margaret Nelson and Anthony Pusateri. These partnerships have contributed to the success of his innovative projects and the advancement of biotechnology.
Conclusion
Michael William Mosesson's contributions to recombinant protein production highlight his role as a key innovator in biotechnology. His patented methods not only address significant challenges in the field but also pave the way for future advancements in medical therapies.